Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.93 USD | -1.00% | +3.12% | +19.49% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
Financials (USD)
Sales 2024 * | 3.04M | Sales 2025 * | 12.25M | Capitalization | 585M |
---|---|---|---|---|---|
Net income 2024 * | -200M | Net income 2025 * | -222M | EV / Sales 2024 * | 138 x |
Net cash position 2024 * | 168M | Net cash position 2025 * | 170M | EV / Sales 2025 * | 33.9 x |
P/E ratio 2024 * |
-3.05
x | P/E ratio 2025 * |
-3.42
x | Employees | 224 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37% |
Latest transcript on IGM Biosciences, Inc.
1 day | -1.00% | ||
1 week | +3.12% | ||
Current month | +3.12% | ||
1 month | +13.36% | ||
3 months | -9.56% | ||
6 months | +83.89% | ||
Current year | +19.49% |
Managers | Title | Age | Since |
---|---|---|---|
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 03-01-31 |
Misbah Tahir
DFI | Director of Finance/CFO | 49 | 18-12-31 |
T. S. Harigopal
COO | Chief Operating Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 21-01-25 |
M. Wilsey
BRD | Director/Board Member | 71 | 19-01-30 |
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 03-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% | ||
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 9.93 | -1.00% | 263,284 |
24-05-06 | 10.03 | -0.40% | 163,376 |
24-05-03 | 10.07 | +6.79% | 182,448 |
24-05-02 | 9.43 | -0.53% | 190,571 |
24-05-01 | 9.48 | -1.56% | 187,893 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.49% | 585M | |
+10.44% | 107B | |
+0.82% | 106B | |
+7.83% | 23.47B | |
-13.89% | 21.9B | |
-6.50% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- IGMS Stock